Patents by Inventor Mathias Emil Egermark

Mathias Emil Egermark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10231639
    Abstract: The present invention relates to a method of diagnosing whether a subject with no known history of atrial fibrillation is suffering from atrial fibrillation, or not, said method comprising the steps of a) determining the amount of a BNP-type peptide in a sample of said subject; b) comparing the amount the BNP-type peptide to a reference, and c) assessing intermittent ECG recordings obtained from said subject over a period of at least one week by using a handheld ECG device.
    Type: Grant
    Filed: April 19, 2016
    Date of Patent: March 19, 2019
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Mathias Emil Egermark, Edelgard Anna Kaiser, Ursula-Henrike Wienhues-Thelen, Christian Zaugg, Andre Ziegler, Marten Rosenquist, Viveka Frykmann-Kull, Emma Svennberg, Leif Friberg
  • Publication number: 20170296078
    Abstract: The present invention relates to a method of diagnosing whether a subject with no known history of atrial fibrillation is suffering from atrial fibrillation, or not, said method comprising the steps of a) determining the amount of a BNP-type peptide in a sample of said subject; b) comparing the amount the BNP-type peptide to a reference, and c) assessing intermittent ECG recordings obtained from said subject over a period of at least one week by using a handheld ECG device.
    Type: Application
    Filed: April 19, 2016
    Publication date: October 19, 2017
    Inventors: Mathias Emil Egermark, Edelgard Anna Kaiser, Ursula-Henrike Wienhues-Thelen, Christian Zaugg, Andre Ziegler, Marten Rosenquist, Viveka Frykmann-Kull, Emma Svennberg, Leif Friberg